


The firm is a global investor, focused on Northern and Eastern Europe, Asia, and the US, and acquires or finances high quality, market leading, mid-market companies in industries with strong growth potential.
Fund | Fund size | Open date | Strategy |
00000000Â 000000Â 00000Â 0 |
0000 |
Dec 2021 |
0000000 |
00000000Â 000000Â 00000Â 00 |
0000 |
Oct 2021 |
0000000 |
LSP Dementia Fund | click to see > | Jan 2021 | Growth equity |
Fund | Fund size | Close date | Strategy |
00000000Â 000000Â 000000000Â 0 |
0000 |
Nov 2022 |
0000000 |
00000000Â 000000Â 00000Â 00 |
0000 |
Sep 2022 |
0000000 |
Life Sciences Partners VII (LSP 7) | click to see > | Feb 2022 | Growth equity |
Fund | Fund size | Inception date | Strategy |
00000000Â 000000Â 0000000 0 |
0000 |
Dec 2022 |
0000000 |
00000000Â 0000Â 00000000Â 00 |
0000 |
Nov 2022 |
0000000 |
EQT IX Co-Investment I | click to see > | Apr 2022 | Co-investment |
Strategy | Region | Sector | Specific Focus |
00000000 |
000000 00000 |
0000000000 |
0000000000 |
000000 |
000000 00000 |
00000000 |
00000000 |
00000000 |
0000000 |
0000000000000 |
0000000000 |
0000000 |
0000000 / 000000 00000 |
0000000 |
000000000000 |
0000000000 |
0000000000 |
0000000000 |
|
00000000 |
|
00000000 |
|
Visit the database to view EQT fund focus details and more >
Head Office
Regeringsgatan 25
Stockholm
SE-111 53
Sweden
+46 8 506 55 300
Name | Job Title | Location | |
Mr. Christian Sinding | CEO and Managing Partner | Zurich, Switzerland |
000000@000000.000 |
Mr. Lennart Blecher | Deputy Managing Partner | Stockholm, Sweden |
00000@000000.000 |
Ms. Sophie Walker | Head of Sustainability – Private Capital | London, UK |
00000000@000000.000 |
Mr. Matthias Fackler | Partner & Head of EQT Infrastructure | Stockholm, Sweden |
000000@000000.000 |
00 0000 0000000 |
0000000 000000 00000 |
0000000, 00 |
00000@000000.000 |
In October 2020, Bridgepoint completed its acquisition of EQT’s credit business.
In November 2021, the firm acquired the Amsterdam-based venture capital firm Life Science Partners in order to strengthen its position in the healthcare sector. At the time of acquisition, LSP had €2.2 billion of assets under management.
EQT may add a strategy that bridges early-stage life sciences investing and buyouts, Michael Bauer, co-head of EQT’s global healthcare sector team, told Private Equity International, noting that it won’t rule out a life sciences growth fund in the medium term.
Copyright PEI Media
Not for publication, email or dissemination